Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Celularity Inc. announced it has received confirmation from Nasdaq that it has regained compliance with the exchange's periodic financial reporting requirements following the filing of its second-quarter 2026 Form 10-Q.
S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year high Treasury yields, and Iran sanctions.
Filed: 2026-09-29 AccNo: 0001493152-26-044917 Size: 226 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits